Search tool

Most clients entering treatment for cocaine in Europe are self-referred, in outpatient settings, in stable accomodation, male, with a range of employment statuses and use several times a week

Infographic: clients entering treatment for cocaine in Europe

This infographic, developed to accompany the miniguide Stimulants: health and social responses in Europe presents some key statistics on clients entering treatment with cocaine as their primary drug, in the EU-27, Norway...

EMCDDA webinar: Preparing for the future — applying a foresight approach in the drugs field

Recording of the EMCDDA webinar: Preparing for the future — applying a foresight approach in the drugs field (2 June 2022).

Map showing estimates of prevalence of high risk opioid use in Europe. Rates range from below 1 to around 8 per 1000.

Last year prevalence of high-risk opioid use among adults in Europe

This infographic, developed to accompany the miniguide Opioids: health and social responses in Europe presents some key statistics on high risk opioid use among adults in the EU-27, Norway and Turkey...

While last year cocaine use among young people is low, in many countries in Europe it is close to 3%.

Infographic: cocaine use in the last year in Europe – young adults (15-34)

This infographic, developed to accompany the miniguide Stimulants: health and social responses in Europe presents some key statistics on cocaine use among young people (15-34) in the EU-27, Norway and Turkey...

EMCDDA webinar: Drug consumption rooms in Europe

Recording of the EMCDDA webinar: Drug consumption rooms in Europe held 2 June 2022.

Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%

At a glance — estimates of drug use in the European Union (updated June 2022)

Graphic shows estimates of prevalence of use for different drugs in the European Union (EU-27). This graphic is take from the European Drug Report 2021. Full source data and methods and...

Most clients entering treatment for amphetamines in Europe are self-referred, in outpatient settings, in stable accomodation, male, with a range of employment statuses and use several times a week

Infographic: clients entering treatment for amphetamines in Europe

This infographic, developed to accompany the miniguide Stimulants: health and social responses in Europe presents some key statistics on clients entering treatment with amphetaminces as their primary drug, in the EU-27, Norway...

screen shot of Franz Pietsch before a European and Austrian flag making a speech

Launch of the 2022 European Drug Report: speech by Chair of EMCDDA Management Board Franz Pietsch

Online press conference on occasion of the launch of the 2022 European Drug Report. Presentation by Chair of the EMCDDA Management Board Franz Pietsch A transcript of the speech is available here.

photo of Commissioner Ylva Johansson during her video speech for the launch of the 2022 European Drug Report

Launch of the 2022 European Drug Report: speech by Commissioner Ylva Johansson

Online press conference on occasion of the launch of the 2022 European Drug Report. Presentation by Ylva Johansson, European Commissioner for Home Affairs.

Thumbnail from video — shows Alexis Goosdeel in front on an image of a smoke cloud with the words 'New challenges'

Recording of the online launch event of the European Drug Report 2022, 14 June 2022

Watch a recording of the launch event of the European Drug Report 2022, which took place in an online press conference on 14 June 2022. Event details Date: 14 June 2022 at ...